Share this
General Catalyst Leads Eleanor Health’s $50 Million Series C
Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III
Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion
Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II
Baylis Medical Agrees to Sell to Boston Scientific for $1.75 Billion
Flexion Therapeutics Agrees to Sell to Pacira BioSciences
Warby Parker – Direct Listing
ZOLL Medical Agrees to Acquire Itamar Medical for $538 Million
Vividion Therapeutics Agrees to Sell to Bayer for up to $2 Billion
Lyell Immunopharma – $425 Million IPO
Cedar Cares Agrees to Acquire OODA Health
Pan Pacific International Holdings Agrees to Acquire Gelson's
Horizon Therapeutics to Acquire Viela Bio
Celularity to Go Public Through SPAC Merger
Olive Closes $225 Million Financing, Acquires Verata Health
Ovid - $75 Million IPO
VelosBio Agrees to Sell to Merck for $2.75 Billion
AppHarvest to Combine With Novus Capital, a Special Purpose Acquisition Company
Forbius Agrees to Sell to Bristol Myers Squibb
ArcherDX Agrees to Combine With Invitae in $2.7 Billion Deal
Avidity Biosciences - $289 Million IPO
Vaxcyte - $288 Million IPO
Reata Pharmaceuticals – $505 Million Follow-On Offering
argenx – $557 Million Follow-On Offering
Innate Pharma - $79 Million IPO
Vir Biotechnology - $143 Million IPO
ERYTECH – $144 Million IPO
Cooley Advises on Nightstar + NuCana IPOs
Aridis – $26 Million IPO
Advaxis – $30 Million Registered Direct Offering
Recro Pharma – $15 Million Follow-On
Gemphire Therapeutics – $30 Million IPO
Syros – $58 Million IPO
Syros IPO – $58 Million
Selecta Biosciences – $74 Million IPO
Oncobiologics – $40 Million IPO and Private Placement
Inotek Pharmaceuticals – $50 Million Follow-On
Auxogyn and Fertility Authority Announce Merger
AveXis – $95 Million IPO
WAVE Life Sciences - $102 Million IPO
Voyager Therapeutics - $80.5 Million IPO
Strongbridge Biopharma IPO
Aclaris Therapeutics IPO
NantKwest IPO - $238 Million IPO
ProNAi Therapeutics - $158 Million IPO
Chiasma Completes $117 Million IPO
Celyad Completes IPO
NantKwest – $238 Million IPO
Catabasis Completes $69 Million IPO
ProNAi – $158 Million IPO
MINDBODY Completes $100 Million IPO
HTG Completes its Initial Public Offering
Aduro Completes $137 Million IPO
KemPharm Completes its IPO
Cidara Completes Initial Public Offering
Invitae Completes $117 Million Initial Public Offering
Ascendis Pharma closes $124 million IPO
Bellicum Pharmaceuticals $160 million IPO
TRACON Pharmaceuticals Completes Initial Public Offering
DBV Technologies Completes Concurrent Public Offerings
Sientra Completes $75 Million Initial Public Offering
Demira Prices $125 Million IPO
T2 Biosystems IPO
Vitae Pharmaceuticals Completes Initial Public Offering
Otonomy $100 Million IPO
Immune Design $63 Million Initial Public Offering
HealthEquity $146 Million Initial Public Offering
Intersect ENT Initial Public Offering
Minerva Neurosciences $32.7 Million IPO
Kite Pharma $146 Million Initial Public Offering
TriVascular Initial Public Offering
Vital Therapies Initial Public Offering
Cooley Advises Underwriters on Vital Therapies IPO
Amedica Initial Public Offering
Genocea Biosciences IPO
Apollo Endosurgery Agreement Acquire Obesity Intervention Division of Allergan
Minerva – $58 Million Follow-On Offering
Merus IPO – $61 Million
Bionano Genomics Initial Public Offering